Task: Answer the following question about the molecule with SMILES CCCC(C)C1(CC)C(=O)[N-]C(=S)NC1=O.[Na+].
Description: Is it known if this drug is the first approved in its class, regardless of the indication or route of administration, acting on a specific target?
Answer: No
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCCC(C)C1(CC)C(=O)[N-]C(=S)NC1=O.[Na+]
CCCC(C)C1(CC)C(=O)[N-]C(=S)NC1=O.[Na+]
sodium;5-ethyl-5-pentan-2-yl-2-sulfanylidenepyrimidin-3-ide-4,6-dione
Is it known if this drug is the first approved in its class, regardless of the indication or route of administration, acting on a specific target?